Natixis Investment Managers International’s Bio-Rad Laboratories Class A BIO Stock Holding History

Natixis Investment Managers International’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-483	Closed	-$121K	–	716
2018 Q1	$121K	Buy	+483	New	+$123K	0.01%	398
2017 Q4	–	Sell	-632	Closed	-$140K	–	181
2017 Q3	$140K	Sell	632 -268	-30%	-$60.3K	0.01%	341
2017 Q2	$204K	Hold	900	–	–	0.02%	309
2017 Q1	$179K	Hold	900	–	–	0.02%	323
2016 Q4	$164K	Buy	+900	New	+$153K	0.02%	362

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Natixis Investment Managers International's BIO Position: Q2 2018 in Review

Natixis Investment Managers International sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2018, closing a stake of 483 shares — an estimated $121K sold.

Natixis Investment Managers International first reported a position in BIO in Q4 2016 and held it in 5 quarters. The position peaked at $204K in Q2 2017. 327 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

Natixis Investment Managers International reported no remaining Bio-Rad Laboratories Class A position as of Q2 2018 after selling out during the quarter.
Natixis Investment Managers International sold 483 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $121K.
Natixis Investment Managers International first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 5 quarters.
Natixis Investment Managers International's Bio-Rad Laboratories Class A position peaked at $204K in Q2 2017.
327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on Natixis Investment Managers International's 13F filing for Q2 2018, filed 14 Aug 2018.